|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-3-29
|
|
pubmed:abstractText |
To compare luteinizing hormone-releasing hormone (LHRH) agonists with orchiectomy or diethylstilbestrol, and to compare antiandrogens with any of these three alternatives.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
132
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
566-77
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10744594-Androgen Antagonists,
pubmed-meshheading:10744594-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10744594-Clinical Trials, Phase II as Topic,
pubmed-meshheading:10744594-Diethylstilbestrol,
pubmed-meshheading:10744594-Disease Progression,
pubmed-meshheading:10744594-Disease-Free Survival,
pubmed-meshheading:10744594-Gonadotropin-Releasing Hormone,
pubmed-meshheading:10744594-Humans,
pubmed-meshheading:10744594-Male,
pubmed-meshheading:10744594-Orchiectomy,
pubmed-meshheading:10744594-Prospective Studies,
pubmed-meshheading:10744594-Prostatic Neoplasms,
pubmed-meshheading:10744594-Quality of Life,
pubmed-meshheading:10744594-Randomized Controlled Trials as Topic,
pubmed-meshheading:10744594-Sensitivity and Specificity,
pubmed-meshheading:10744594-Survival Analysis
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
|
|
pubmed:affiliation |
Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, Illinois 60601-7680, USA. Jerome.Seidenfeld@bcbsa.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
